TOVX earnings
Theriva Biologics (TOVX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- TOVX beat EPS estimates in 3 of its last 15 reports.
TOVX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 12, 2026 | -0.03 | -0.06 | 50.00% | $0.00 |
| Q2 2026 | Aug 11, 2026 | -0.07 | -0.06 | -27.27% | $0.00 |
| Q1 2026 | May 5, 2026 | -0.05 | -0.05 | 0.00% | $300.00K |
| Q3 2025 | Nov 12, 2025 | -0.45 | -0.38 | -18.42% | – |
| Q2 2025 | Aug 11, 2025 | -1.93 | -0.38 | -407.89% | – |
| Q1 2025 | May 14, 2025 | -1.55 | -4.19 | 63.01% | – |
| Q3 2024 | Nov 12, 2024 | -6.81 | -6.25 | -8.96% | – |
| Q2 2024 | Aug 13, 2024 | -10.75 | -4.75 | -126.32% | – |
| Q1 2024 | May 7, 2024 | -7.50 | -0.34 | -2105.88% | – |
| Q4 2023 | Mar 25, 2024 | -8.00 | -0.41 | -1851.22% | $758.00K |
| Q3 2023 | Nov 13, 2023 | -4.75 | -0.37 | -1183.78% | – |
| Q2 2023 | Aug 8, 2023 | -8.50 | -0.36 | -2261.11% | – |
| Q1 2023 | May 11, 2023 | -7.50 | -0.32 | -2243.75% | – |
| Q4 2022 | Mar 30, 2023 | -9.00 | 0.33 | -2827.27% | – |
| Q3 2022 | Nov 10, 2022 | -8.25 | -0.39 | -2015.38% | – |